Details for 2016860952
Up to date per 01.04.2026
Actions
Details for 2016860952
Granted/Registered
European Patent
05.09.2018 A
26.01.2022 B1
29.10.2015
US
201562248255 P
A61K 39/08 20060101AFI20201201BHEP
Owner
ReVance Therapeutics, Inc.7555 Gateway Blvd. Newark, CA 94560US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
RUEGG, Curtis L.826 Shepard Way Redwood City, California 94062US
WAUGH, Jacob M.555 Bryant Street 817 Palo Alto, California 94301US
Information about Fees